The goal of the study is to determine whether the use of Human Fibrinogen Concentrate (RiaSTAP) will decrease blood loss and the need for component blood therapy in neonates and infants undergoing cardiopulmonary bypass.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Postoperative Blood Loss After Surgery (Estimated Blood Loss (EBL))
Timeframe: Within 24 hours of surgery
Post-operative 2 hr Hemoglobin (Hg) mg/dL Measure
Timeframe: 2 hour
Post-operative 24-hr Hemoglobin (Hg) mg/dL
Timeframe: 24 hr
Post-operative 2 hr Hematocrit (HCT) Measure
Timeframe: 2 hour
Post-operative 24 hr Hematocrit (HCT) Measure
Timeframe: 24 hour
Post-operative 2 hr Platelets Count Test (PLT) 10K/uL
Timeframe: 2 hour
Post-operative 24 hr Platelets Count Test (PLT) 10K/uL
Timeframe: 24 hour
Post-operative 2 hr Prothrombin (PT) Seconds
Timeframe: 2 hour
Post-operative 24 hr Prothrombin (PT) Seconds
Timeframe: 24 hour
Post-operative 2 hr International Normalize Ratio (INR)
Timeframe: 2 hour
Post-operative 24 hr International Normalize Ratio (INR)
Timeframe: 24 hour
Post-operative 2 hr Partial Thromboplastin Time (PTT) Seconds
Timeframe: 2 hour
Post-operative 24 hr Partial Thromboplastin Time (PTT) Seconds
Timeframe: 24 hour
Post-operative 2 hr Fibrinogen mg/dL
Timeframe: 2 hour
Post-operative 24 hr Fibrinogen mg/dL
Timeframe: 24 hour